According to Travere Therapeutics's latest financial reports the company's current revenue (TTM) is $0.19 B. In 2022 the company made a revenue of $0.18 B a decrease over the years 2021 revenue that were of $0.22 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.19 B | 6.56% |
2022 | $0.18 B | -17.98% |
2021 | $0.22 B | 14.71% |
2020 | $0.19 B | 13.11% |
2019 | $0.17 B | 6.75% |
2018 | $0.16 B | 6.01% |
2017 | $0.15 B | 15.98% |
2016 | $0.13 B | 33.73% |
2015 | $99.89 M | 254.18% |
2014 | $28.2 M | |
2013 | N/A | |
2012 | N/A | |
2011 | N/A |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $0.86 B | 334.26% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $0.22 M | -99.89% | ๐บ๐ธ USA |